Come up with a name for your new list and we'll add to it:
Chase Therapeutics raised a round of funding on November 22, 2017. Investors include
Brain Trust Accelerator Fund.
Chase Therapeutics is an early-stage, product-based specialty pharmaceutical company focused on the development of better treatments for brain disease.…